Sunny Sharma
Senior Managing Director @ OrbiMed
Mumbai, India
Sunny Sharma is a venture - series unknown investor at OrbiMed in Mumbai focused on Health Care and Biotechnology. Sunny Sharma is based out of Mumbai, Maharashtra and is the Partner and Senior Managing Director Asia of OrbiMed and also Boar Member of TruNativ. Sunny previously worked at Investor Growth Capital Limited as a Venture Partner and Vice President. Sunny Sharma attended the Christian Medical College & Hospital. Sunny Sharma has been awarded the Vipin Khanna Memorial Gold Medal for graduating as the best intern.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 73%
Last updated:
For AI agents: llms.txt
Industries Sunny Sharma invests in
Stages Sunny Sharma invests in
Countries Sunny Sharma invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 8 (73%)
- Biotechnology 4 (36%)
- Medical 3 (27%)
- Health Diagnostics 3 (27%)
- E-Commerce 2 (18%)
Stage
- Venture - Series Unknown 4 (36%)
- Series C 2 (18%)
- Private Equity 2 (18%)
- Series A 1 (9%)
- Series B 1 (9%)
Country
- India 8 (73%)
- United States 2 (18%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Iswarya Fertility Center provides IVF, IUI, egg donation, azoospermia, ovulation induction, and miscarriage treatment solutions. | $37M / Private Equity / Jul 09, 2026 | ||
| Trunative is a producer and distributor of nutrition products under the TruNativ brand targetting health and fitness enthusiasts. | $30M / Series B / Jun 16, 2026 | ||
| Pee Safe was started in 2013, launching the first of its kind toilet seat sanitizer. Since 2017, the company has expanded into several personal hygiene categories including feminine hygiene (pads, tampons, cups, etc), men's intimate hygiene, hand hygiene (Palm Safe), face mask and mist (Pollution Safe), while being one of the leaders in a fewsub-categories. | $32M / Series C / Jan 14, 2026 | ||
| Arcatron Mobility is a medical device startup focused on designing and selling innovative products to enhance lives of people with limited mobility. Arcatron was founded by four engineers of NIT Calicut in June 2015 with a moto of Purpose Driven Innovation.The company has a focus on India’s 1/3rd of 110 million+ elderly citizens needingassistance in carrying out activities of Daily Living (ADL’s) like bathing, toileting, walking. Demand for mobility assistance is increasing due to the rapid rate of aging, spinal cord injuries and obesity. However, the mobility devices available in India are poor quality or unaffordable. Arcatron aims to fix this problem by building world-class mobility devices at affordable prices.Arcatron Mobility has a vision to become domestic market leader in most competing categories and one of the world’s most trusted medical device brands by 2022. | Venture - Series Unknown / Feb 15, 2024 | ||
| Innvolution Med System is a company that operates in the medical device industry. The company was established by a group of leaders with extensive experience in the cardiovascular sector. Innvolution Med System's primary focus is on developing and providing innovative solutions for cardiovascular health. The company's offerings include arange of medical devices and technologies designed to improve patient outcomes and enhance the quality of care in the cardiovascular field. | Private Equity / Apr 10, 2023 | ||
|
LifeWell
|
LifeWell is a new entity formed through the merger of LifeCell’s diagnostics business and MFine. | $80M / Venture - Series Unknown / Jul 11, 2022 | |
| LifeCell is a private stem cell bank that brings the concept of umbilical cord stem cell banking to India.Set up in the year 2004, LifeCell started out as an umbilical cord stem cell banking company and has now grown to become a comprehensive stem cells solutions provider with a complete spectrum of services including multi-service stem cellbanking, R&D, stem cell clinical trials, and stem cell therapy. Based in Chennai, LifeCell has a spread over 100 service centers in India and the GCC countries. | $34.6M / Venture - Series Unknown / Sep 21, 2021 | ||
| Who we are - India's most convenient online pharmacyNetmeds.com, India Ki Pharmacy, is brought to you by the Dadha & Company – one of India’s most trusted pharmacies, with over 100 years’ experience in dispensing quality medicines. At netmeds.com, we help you look after your own health effortlessly as well as take care of loved oneswherever they may reside in India. You can buy and send medicines from any corner of the country - with just a few clicks of the mouse. | $50M / Series A / Oct 26, 2015 | ||
| Asian Institute of Medical Sciences is a 425 bedded super specialty hospital in Delhi NCR, India which is dedicated to provide accessible, affordable and best available healthcare services in India. Accredited by NABH and NABL, Asian Hospital Faridabad provides preventive, diagnostic, therapeutic, rehabilitative, palliative and supportive servicesall under one roof and is designed to meet patient care and research requirements of the new millennium.Asian Institute of Medical Sciences offers comprehensive multi-specialty tertiary care facilities through its 14 centres of excellence.- ASIAN CANCER CENTRE - ASIAN CENTRE FOR BONE MARROW TRANSPLANT - ASIAN HEART CENTRE - ASIAN CENTRE FOR ADVANCED SURGERY- ASIAN CENTRE FOR NEUROLOGY AND NEUROSURGERY - ASIAN CENTRE FOR UROLOGY AND KIDNEY TRANSPLANT - ASIAN CENTRE FOR RENAL DISEASES - ASIAN CENTRE FOR BONE AND JOINTS - ASIAN CENTRE FOR ADVANCED IMAGING - ASIAN CENTRE FOR GASTROENTEROLOGY - ASIAN CENTRE FOR MOTHER AND CHILD- ASIAN CENTRE FOR BARIATRIC & METABOLIC SURGERY - ASIAN CENTRE FOR AESTHETIC SURGERY & MEDICINE - ASIAN IVF CENTRE | Venture - Series Unknown / Jan 09, 2014 | ||
| Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continuesto develop additional antibody products using its proprietary technologies.Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets. | $40M / Series D / Oct 12, 2006 | ||
| See all 11 investments → | |||
Co-Investors
About OrbiMed
OrbiMed executes multiple investment strategies, including private equity for startups, public equity for traded entities, and private credit for commercial-stage companies. It offers structured debt and royalty monetization as non-dilutive financing solutions for owners of intellectual property and medical diagnostics. The firm manages a global portfolio that supports the development of new therapies, medical devices, and healthcare information technology systems.
OrbiMed Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dina Chaya
Partner
|
|||
Kevin Koch
Venture Partner
|
|||
Rishi Gupta
Private Equity Partner
|
|||
|
Sunny Sharma
Senior Managing Director
|
|||
Tadd S. Wessel
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sunny Sharma invest in?
Sunny Sharma invests primarily in Health Care, Biotechnology and Medical startups, most often at Venture - Series Unknown and Series C stage. Most of the 11 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sunny Sharma?
Public channels for Sunny Sharma include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sunny Sharma last invest?
The most recent investment recorded for Sunny Sharma closed in Jul 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
